[Skip to Navigation]
Sign In
Viewpoint
September 5, 2017

Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders

Author Affiliations
  • 1Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut
  • 2The Yale Psychiatric Hospital, Yale New Haven Health, New Haven, Connecticut
JAMA. 2017;318(9):793-794. doi:10.1001/jama.2017.10697
Add or change institution
×